Birk Venture Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
Professionals
  • Investments
  • 17
  • Portfolio
  • 5
  • Exits
  • 6
Exits

Birk Venture General Information

Description

Birk Venture is an investment firm founded in 2010 and based in Oslo, Norway. The firm seeks to invest in the pharmaceuticals, diagnostics, medical devices and instruments, biotechnology and consumer health sectors.

Contact Information

Year Founded
2010
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Karenslyst allé 8b
  • 0278 Oslo
  • Norway
+47 908 00 000

Birk Venture Investments (17)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Accession Therapeutics 22-Sep-2021 Early Stage VC Other Healthcare Technology Systems Pre-Clinical Trials 0000 0000 00000000
0000000000 09-Feb-2017 00 000000000 0000 Drug Discovery Clinical Trials - Phase 1
0000000 0000000000 01-Jan-2016 00000 00000 Drug Discovery Generating Revenue 0000 0000 00000000
000000000000 00000 30-Oct-2014 0000 000.00 Biotechnology Generating Revenue/Not Profitable
000000000 26-Jun-2013 00000 00000 00.00 Drug Discovery Generating Revenue/Not Profitable 0000 0000 00000000
000000 0000000000 08-Jun-2013 00000 00000 000.00 Biotechnology Generating Revenue
0000 000000000000 17-Oct-2012 00000 00000 Drug Discovery Clinical Trials - Phase 1 0000 0000 00000000
0000000 19-Aug-2012 00000 00000 Drug Discovery Generating Revenue 0000 0000 00000000
Targovax 01-Feb-2012 Early Stage VC 00.000 Biotechnology Generating Revenue 0000 0000 00000000
Nordic Nanovector 22-Jan-2012 Early Stage VC 00.000 Biotechnology Generating Revenue
You’re viewing 10 of 17 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Birk Venture Exits (6)

Company Name Exit Date Exit Type Exit Size
Strongbridge Biopharma 04-Oct-2017 Secondary Transaction - Open Market 0000
000000000 07-Apr-2017 000 000.00
000000 0000000000 23-Mar-2015 000 000.00
00000000 16-Jun-2014 000
Algeta 06-Mar-2014 Merger/Acquisition 00.00
PCI Biotech Holding 18-Jun-2008 IPO 000.00
To view Birk Venture’s complete exits history, request access »

Birk Venture Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Birk Venture Team (2)

Name Title Deals Funds Boards Office
Hans Ivar Robinson Founder, Chief Executive Officer and Chairman 00 0 Oslo, Norway
Per-Oluf Olsen Co-Investor and External Partner 0 0 Oslo, Norway
To view Birk Venture’s complete team members history, request access »

Birk Venture Co-Investors (1)

Name With Exits Lead Partner Series Industry
Primavera Capital Group 0 0 Series chart Industry bar
To view Birk Venture’s complete co-investors history, request access »